RELATED: Pfizer to seek clearance soon; new data shows its COVID-19 vaccine is 95% effectiveThe companies plan to globally produce 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021, according to a press release.It could take the FDA up to four weeks to approve Pfizer’s request.
AdvertisementIf approved, the plan to distribute the 2-dose vaccine will be left up to individual countries although most agree that first responders and other at-risk healthcare workers should get the first injections.
Medical experts say it could be several more months before the vaccine is widely available to the public. An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical.